Fig. 4From: Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody PamrevlumabRelative expression profiles of selected mesenchymal, ECM remodeling genes in response to RT and pamrevlumab (FG-3019) at 18 and 30 weeks. Relative expression is normalized to contemporaneous non-irradiated controls (mean ± SE)Back to article page